Retina/Vitreous

Top Story

Zimura-Lucentis combination safe in wet AMD patients in phase 2a trial

November 13, 2018
Meeting NewsVideo

VIDEO: Sustained-release ranibizumab ‘exceeds expectations’ for wet AMD

November 9, 2018
CHICAGO — Carl D. Regillo, MD, gives an update on the phase 2 LADDER study, a four-arm trial of sustained-release ranibizumab (Genentech), at the American Academy…
Meeting News

Repeated intravitreal sirolimus treatments improve vitreous haze

November 7, 2018
CHICAGO — The results of the integrated SAKURA program showed every-other-month dosing with intravitreal sirolimus improved ocular inflammation and vitreous haze…

Compact Imaging, Novartis collaborate to develop home retinal monitoring system

November 7, 2018
Compact Imaging has signed a collaboration agreement with Novartis Pharma to develop a home-based monitor to detect progression of age-related macular degeneration and…
More Headlines »
Case Report

Mushroom-Shaped Secondary Vasoproliferative Tumor

Ophthalmic Surgery, Lasers and Imaging Retina, Volume 5
Online Only, September 1, 2012
The authors report a clinical and echographic correlation of a retinal vasoproliferative tumor that assumed a mushroom…
More »
CME

Innovative Targeting of IOP, Emerging New Science in Glaucoma Management

This activity is supported by an educational grant from Bausch + Lomb.

Glaucoma is the leading cause of irreversible blindness worldwide, with an estimated 70 million people affected by the…
More »
Video
Meeting News

VIDEO: Vision screenings important for underserved communities

November 1, 2018
More »

Zimura-Lucentis combination safe in wet AMD patients in phase 2a trial

November 13, 2018
Zimura, a complement factor C5 inhibitor, was found to be well tolerated in combination with Lucentis in a phase 2a clinical trial, Ophthotech…

Meeting NewsVideo

VIDEO: Sustained-release ranibizumab ‘exceeds expectations’ for wet AMD

November 9, 2018
CHICAGO — Carl D. Regillo, MD, gives an update on the phase 2 LADDER study, a four-arm trial of sustained-release ranibizumab (Genentech), at…

Meeting News

Repeated intravitreal sirolimus treatments improve vitreous haze

November 7, 2018
CHICAGO — The results of the integrated SAKURA program showed every-other-month dosing with intravitreal sirolimus improved ocular inflammation…

Compact Imaging, Novartis collaborate to develop home retinal monitoring system

November 7, 2018
Compact Imaging has signed a collaboration agreement with Novartis Pharma to develop a home-based monitor to detect progression of age-related…

Clearside’s retinal vein occlusion therapy fails to meet phase 3 endpoint

November 6, 2018
Xipere, an investigational treatment for retinal vein occlusion, did not achieve its phase 3 clinical trial primary endpoint, Clearside Biomedical…

Ophthotech acquires Versant Ventures-backed Inception 4

November 5, 2018
Ophthotech Corp. has acquired Inception 4 Inc. and its small molecule inhibitors of HtrA1, which are under development for the treatment of a range…

Meeting NewsVideo

VIDEO: Pearls on using the ForeseeHome to detect wet-AMD

November 5, 2018
CHICAGO — David S. Chin Yee, MD, discusses best practices in using the ForeseeHome device to monitor AMD patients' transition from dry to wet…

Meeting NewsVideo

VIDEO: Surgeons learning benefits of hypersonic vitrectomy

November 2, 2018
CHICAGO — At the American Academy of Ophthalmology meeting here, Carl C. Awh, MD, discusses some of the advantages surgeons are learning about…

ProQR granted license to Ionis’ retinitis pigmentosa candidate

November 2, 2018
ProQR Therapeutics has acquired worldwide licensing rights to Ionis Pharmaceuticals’ QR-1123, an RNA medicine for autosomal dominant retinitis…

Meeting NewsVideo

VIDEO: Allegro updates progress of Luminate for DME

November 2, 2018
CHICAGO — At the Ophthalmology Innovation Summit at AAO, Vicken Karageozian, MD, CEO of Allegro Ophthalmics, discusses the progress of…

Grand Rounds at the New England Eye Center

Woman presents with vision loss and cough

Ocular Surgery News U.S. Edition, November 10, 2018
Lauren Bierman, MD; Nora Muakkassa, MD; Lana Rifkin, MD
A 45-year-old woman with no significant medical or ocular history presented to the New England Eye Center with 1 year of floaters and gradual loss of…

In the Journals

Oral steroids for nonarteritic anterior ischemic optic neuropathy did not significantly improve visual acuity

November 1, 2018
Oral steroids did not significantly improve visual acuity in patients with nonarteritic anterior ischemic optic neuropathy, but they did improve…

Meeting NewsVideo

VIDEO: Vision screenings important for underserved communities

November 1, 2018
CHICAGO — Richard Lee, MD, PhD, of Bascom Palmer Eye Institute at the University of Miami, discusses how his team conducts vision screenings…

Meeting News

Baseline status may not affect outcomes of fluocinolone acetonide intravitreal insert

October 31, 2018
CHICAGO — Baseline best corrected visual acuity, vitreous haze, OCT and other factors do not appear to have an impact on outcomes of patients…

Meeting News

Anatomic results maintained at end of brolucizumab studies

October 30, 2018
CHICAGO — Brolucizumab maintained non-inferiority to aflibercept regarding best corrected visual acuity change at week 96, which was the end of…

Meeting NewsVideo

VIDEO: ForeseeHome helps monitor AMD progression

October 30, 2018
CHICAGO — Lisa K. Feulner, MD, PhD, discusses the importance of early detection of a transition from dry to wet age-related macular…

Meeting News

Tocilizumab reduces haze, increases visual acuity in noninfectious uveitis

October 30, 2018
CHICAGO — Repeated intravitreal injections of tocilizumab 4 mg/kg and 8 mg/kg in patients with noninfectious uveitis improved visual acuity and…

Meeting News

Retinal malpractice issues involve ROP, injections and wrong events

October 29, 2018
CHICAGO — Even though malpractice lawsuits for retinopathy of prematurity are rare, they are expensive, according to AAO President-elect…

Meeting News

OpRegen shows positive phase 1/2a study results for dry AMD

October 29, 2018
CHICAGO — OpRegen, a retinal pigment epithelium cell therapy transplant for dry age-related macular degeneration, has shown signs of improving…

Intravitreal corticosteroids superior in treatment of uveitic macular edema

October 29, 2018
CHICAGO — Intravitreal triamcinolone and intravitreal dexamethasone sustained-release implant were both superior to periocular triamcinolone…

More Headlines »